Barclays’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $38.5M | Sell |
426,256
-31,773
| -7% | -$2.92M | 0.01% | 820 |
|
|
2025
Q4 | $41.2M | Sell |
458,029
-31,027
| -6% | -$2.94M | 0.01% | 877 |
|
|
2025
Q3 | $48.2M | Sell |
489,056
-34,741
| -7% | -$3.44M | 0.01% | 790 |
|
|
2025
Q2 | $47.8M | Sell |
523,797
-40,379
| -7% | -$3.9M | 0.01% | 728 |
|
|
2025
Q1 | $63.9M | Buy |
564,176
+89,223
| +19% | +$9.54M | 0.02% | 568 |
|
|
2024
Q4 | $50.2M | Sell |
474,953
-174,820
| -27% | -$18.8M | 0.01% | 662 |
|
|
2024
Q3 | $70.1M | Sell |
649,773
-51,587
| -7% | -$5.63M | 0.02% | 557 |
|
|
2024
Q2 | $76.1M | Sell |
701,360
-17,372
| -2% | -$2.05M | 0.02% | 482 |
|
|
2024
Q1 | $94.9M | Buy |
718,732
+10,146
| +1% | +$1.27M | 0.03% | 395 |
|
|
2023
Q4 | $86.2M | Sell |
708,586
-363,908
| -34% | -$40.6M | 0.03% | 461 |
|
|
2023
Q3 | $120M | Buy |
1,072,494
+604,652
| +129% | +$76.8M | 0.08% | 255 |
|
|
2023
Q2 | $68.1M | Buy |
467,842
+220,328
| +89% | +$29.9M | 0.04% | 364 |
|
|
2023
Q1 | $32M | Sell |
247,514
-69,680
| -22% | -$8.75M | 0.01% | 654 |
|
|
2022
Q4 | $40.4M | Buy |
317,194
+46,366
| +17% | +$5.38M | 0.02% | 582 |
|
|
2022
Q3 | $28.3M | Buy |
270,828
+52,971
| +24% | +$5.81M | 0.03% | 489 |
|
|
2022
Q2 | $22.9M | Sell |
217,857
-275,926
| -56% | -$32.7M | 0.01% | 668 |
|
|
2022
Q1 | $63.2M | Sell |
493,783
-155,115
| -24% | -$18.7M | 0.05% | 351 |
|
|
2021
Q4 | $80M | Buy |
648,898
+1,145
| +0.2% | +$150K | 0.03% | 417 |
|
|
2021
Q3 | $92M | Buy |
647,753
+51,873
| +9% | +$7.63M | 0.04% | 343 |
|
|
2021
Q2 | $93M | Buy |
595,880
+11,224
| +2% | +$1.82M | 0.04% | 316 |
|
|
2021
Q1 | $90.9M | Buy |
584,656
+113,943
| +24% | +$17.6M | 0.05% | 278 |
|
|
2020
Q4 | $70.4M | Buy |
470,713
+33,656
| +8% | +$4.75M | 0.04% | 350 |
|
|
2020
Q3 | $57.8M | Buy |
437,057
+32,848
| +8% | +$4.29M | 0.03% | 360 |
|
|
2020
Q2 | $46.8M | Sell |
404,209
-11,996
| -3% | -$1.38M | 0.04% | 350 |
|
|
2020
Q1 | $40.8M | Sell |
416,205
-215,378
| -34% | -$28.2M | 0.03% | 369 |
|
|
2019
Q4 | $91.8M | Sell |
631,583
-71,102
| -10% | -$9.81M | 0.05% | 288 |
|
|
2019
Q3 | $93.7M | Sell |
702,685
-216,246
| -24% | -$27.9M | 0.06% | 266 |
|
|
2019
Q2 | $105M | Buy |
918,931
+33,422
| +4% | +$3.91M | 0.06% | 252 |
|
|
2019
Q1 | $110M | Buy |
885,509
+153,319
| +21% | +$17.4M | 0.08% | 209 |
|
|
2018
Q4 | $73.7M | Sell |
732,190
-42,259
| -5% | -$4.75M | 0.06% | 253 |
|
|
2018
Q3 | $98.8M | Buy |
774,449
+46,266
| +6% | +$5.5M | 0.07% | 209 |
|
|
2018
Q2 | $78.8M | Sell |
728,183
-140,682
| -16% | -$15.3M | 0.07% | 240 |
|
|
2018
Q1 | $92M | Buy |
868,865
+232,142
| +36% | +$27M | 0.07% | 234 |
|
|
2017
Q4 | $74.6M | Buy |
636,723
+175,992
| +38% | +$19.9M | 0.06% | 263 |
|
|
2017
Q3 | $52.4M | Sell |
460,731
-19,517
| -4% | -$2.25M | 0.05% | 281 |
|
|
2017
Q2 | $59.9M | Buy |
480,248
+34,708
| +8% | +$4.11M | 0.06% | 234 |
|
|
2017
Q1 | $52.8M | Buy |
445,540
+198,619
| +80% | +$22.5M | 0.06% | 237 |
|
|
2016
Q4 | $24.7M | Sell |
246,921
-57,741
| -19% | -$6.19M | 0.03% | 507 |
|
|
2016
Q3 | $38.5M | Sell |
304,662
-114,998
| -27% | -$14.2M | 0.04% | 312 |
|
|
2016
Q2 | $49M | Sell |
419,660
-189,287
| -31% | -$21.4M | 0.06% | 264 |
|
|
2016
Q1 | $62.7M | Buy |
608,947
+248,434
| +69% | +$24M | 0.1% | 168 |
|
|
2015
Q4 | $35.7M | Sell |
360,513
-5,643
| -2% | -$552K | 0.04% | 370 |
|
|
2015
Q3 | $33.1M | Sell |
366,156
-7,697
| -2% | -$772K | 0.04% | 398 |
|
|
2015
Q2 | $39.6M | Sell |
373,853
-42,278
| -10% | -$4.68M | 0.04% | 375 |
|
|
2015
Q1 | $47.3M | Buy |
416,131
+59,863
| +17% | +$6.83M | 0.05% | 347 |
|
|
2014
Q4 | $39.1M | Sell |
356,268
-23,873
| -6% | -$2.52M | 0.04% | 442 |
|
|
2014
Q3 | $36.9M | Buy |
380,141
+208,345
| +121% | +$20.5M | 0.04% | 435 |
|
|
2014
Q2 | $17.2M | Sell |
171,796
-10,255
| -6% | -$1M | 0.02% | 790 |
|
|
2014
Q1 | $16.6M | Sell |
182,051
-651,928
| -78% | -$60.1M | 0.02% | 808 |
|
|
2013
Q4 | $75.3M | Buy |
833,979
+617,083
| +285% | +$53.4M | 0.08% | 225 |
|
|
2013
Q3 | $17.3M | Buy |
216,896
+19,693
| +10% | +$1.55M | 0.02% | 765 |
|
|
2013
Q2 | $14.3M | Buy |
+197,203
| New | +$14.7M | 0.02% | 831 |
|
Other funds holding ZBH
VCM
VPM
Barclays's ZBH Position: Q1 2026 in Review
Barclays reduced its Zimmer Biomet (ZBH) stake by 6.9% in Q1 2026, selling an estimated $2.92M and leaving 426,256 shares worth $38.5M. The position accounts for 0.01% of the portfolio, ranked #820.
Barclays first reported a position in ZBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $120M in Q3 2023. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- Barclays held 426,256 shares of Zimmer Biomet worth $38.5M as of Q1 2026.
- Barclays sold 31,773 Zimmer Biomet shares in Q1 2026, an estimated $2.92M.
- Zimmer Biomet made up 0.01% of Barclays's portfolio in Q1 2026, its #820 holding.
- Barclays first reported a position in Zimmer Biomet in Q2 2013 and has held it in 52 quarters since.
- Barclays's Zimmer Biomet position peaked at $120M in Q3 2023.
- 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.